Latest News
|
More Articles...
- Milvexian Granted U.S. FDA Fast Track Designation for All Three Indications Under Evaluation in Phase 3 Librexia Program: Ischemic Stroke, Acute Coronary Syndrome and Atrial Fibrillation
- New Data Published on Biosense Webster QDOT MICRO™ Catheter - the Latest Advancement in Focal RF Ablation for Treating AFib
- PaceMate Announces First-in-Market Collaboration with AliveCor to Offer the Only Remote Cardiac Remote Monitoring Platform to Encompass Consumer ECG, Event Monitoring, Heart Failure, and Implantable Cardiac Devices
- Pulnovo Medical Announces 3-Year Follow-up Results from PADN-5 at THT 2023, The Medical Device Maker Breaks New Ground in Heart Failure Treatment
- Revamp Medical secures Series A Funding to Support Clinical Trials for Its Doraya™ Catheter for Treating Heart Failure Patients
- The Role of Natriuretic Peptides in the Diagnosis and Management of Heart Failure Discussed in New Joint Scientific Statement by the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, and Japanese Heart Fail
- Scientific Statement on Diagnosis and Treatment of Iron Deficiency in Heart Failure Released by Heart Failure Society of America
- Sirnaomics Dosed the First Patient in Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Treatment
- Study Shows PulseAI’s Deep Learning Algorithm Outperforms the Apple Watch ECG Algorithm in Detecting Atrial Fibrillation
- Study to Measure Accuracy of Unique Index for Early, Noninvasive Prediction of Worsening Heart Failure
|
|
